C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2011
11/17/2011	US20110281899 Methods of preventing and treating low bone mass diseases
11/17/2011	US20110281895 Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine
11/17/2011	US20110281894 Hemifumarate salt
11/17/2011	US20110281888 Fused Bicyclic Kinase Inhibitors
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281875 Inhibitors of IAP
11/17/2011	US20110281872 Compositions and methods for the prevention and treatment of cancer
11/17/2011	US20110281871 Taar1 ligands
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011	US20110281869 Tetrahydroisoquinolines as antimalarial agents
11/17/2011	US20110281868 Indazole inhibitors of kinase
11/17/2011	US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281847 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/17/2011	US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011	US20110281842 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110281837 3-substituted-6-aryl pyridines
11/17/2011	US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110278549 New fused cyclic compound and organic electronic device
11/17/2011	CA2800578A1 Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors
11/17/2011	CA2799495A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
11/17/2011	CA2799154A1 Indazole inhibitors of kinase
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/16/2011	EP2386553A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2385940A1 2,4,6-tri-(heteroarylphenyl)-pyridines and electron-transporting materials comprising them
11/16/2011	EP2385939A1 Dihydropyridone amides as p2x7 modulators
11/16/2011	EP2285800B1 Quinoline or isoquinoline substituted p2x7 antagonists
11/16/2011	EP2259689B1 Flavor molecules
11/16/2011	EP2231679B1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
11/16/2011	EP2142533B1 Imidazolidinone derivatives
11/16/2011	EP2125785B1 Indole-3-yl-carbonyl-piperidine- derivatives for the treatment of anxiety and depressive disorders via v1a receptor antagonism
11/16/2011	EP2106397B1 A process for preparation of enantiomerically pure esomeprazole
11/16/2011	EP2086959B1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
11/16/2011	EP2027086B1 N-benzoyl-pyrrolidin-3-ylamines as histamine-3 antagonists
11/16/2011	EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity
11/16/2011	EP1899325B1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
11/16/2011	EP1896452B1 N-formyl hydroxylamine compounds
11/16/2011	EP1838693B1 Pyrazole derivatives as pesticides
11/16/2011	EP1746999B1 4-phenylamino-quinazolin-6-yl-amides
11/16/2011	EP1727794B1 Novel benzyl(idene)-lactam derivatives
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN1938291B Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
11/16/2011	CN102245594A Process for the preparation of enantiomerically enriched proton pump inhibitors
11/16/2011	CN102245593A Isoquinolinone derivatives
11/16/2011	CN102245592A A new process for preparing 4- [4-methyl-5- (cl- 10alkylthio/c5-10aryl-cl-6alkylthio) -4h-1, 2, 4-triazol-3- yl] pyridines.
11/16/2011	CN102245591A Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters
11/16/2011	CN102245583A Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
11/16/2011	CN102245578A Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
11/16/2011	CN102245577A 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
11/16/2011	CN102245576A Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
11/16/2011	CN102245183A New compounds v
11/16/2011	CN102241672A 2,3-dipyrrolyl-6-acylaminoquinoxaline compounds and preparation method thereof
11/16/2011	CN102241671A Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
11/16/2011	CN102241670A Preparation method of high-purity chiral sulphoxide compound
11/16/2011	CN102241669A Preparation method of fasudil hydrochloride
11/16/2011	CN102241668A New S-omeprazole salts
11/16/2011	CN102241667A 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
11/16/2011	CN102241666A Method for producing hydrochloride of dopamine D4 receptor agonist A-412997
11/16/2011	CN102241637A 2,3-diphenyl-6-amido quinoxaline compound and preparation method thereof
11/16/2011	CN102241636A Derivative of ligustrazine
11/16/2011	CN102241565A Method for synchronously extracting solanesol and nicotine from tobacco
11/16/2011	CN101516852B Quinoline derivatives with 5-ht-binding properties
11/16/2011	CN101448791B Fxr agonists
11/16/2011	CN101236158B Reticular cell detection method and detection device
11/16/2011	CN101231243B Agent and method for testing reticulocyte
11/16/2011	CN101212973B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/15/2011	US8058452 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058443 making crystalline lenalidomide
11/15/2011	US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011	US8058436 Method for the preparation of enantiomerically pure mirtazapine
11/15/2011	US8058427 Coumarin compounds and their use for treating cancer
11/15/2011	US8058292 Therapeutic agents useful for treating pain
11/15/2011	US8058291 Methods and compositions for the treatment of CNS-related conditions
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8058272 Organic compounds
11/15/2011	US8058269 Oxindole derivatives
11/15/2011	US8058210 Arylphenyl-substituted cyclic keto-enols
11/15/2011	US8058045 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
11/15/2011	US8057921 Ambipolar host in organic light emitting diode
11/15/2011	CA2666975C Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
11/15/2011	CA2632149C Pyrimidine derivatives for the treatment of abnormal cell growth
11/15/2011	CA2477212C Novel arylamidine derivative or salt thereof
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/10/2011	WO2011140296A1 Triazoles as inhibitors of fatty acid synthase
11/10/2011	WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	WO2011140160A1 Bicyclic heteroaryl compounds as gpr119 modulators
11/10/2011	WO2011139891A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites

1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1080